These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 20646542)
1. [Reversion of resistance to cisplatin induced by MG132 in cervical cancer line HCE1 multicellular spheroid]. Wu YL; Yang HJ; Wang KK; Tao GS; Liu YZ; Hu Y Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):287-91. PubMed ID: 20646542 [TBL] [Abstract][Full Text] [Related]
2. Effect of CD147 monoclonal antibody on paclitaxel resistance in HCE1 multicellular spheroids. Hu Y; Wu Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 36(3):192-202. PubMed ID: 21464539 [TBL] [Abstract][Full Text] [Related]
3. [Effect of GM6001 on the model that cervical squamous carcinoma cell line HCE1 multicellular spheroids invade live human umbilical vein endothelium cell monolayers]. Lan J; Wu Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 35(8):868-74. PubMed ID: 20818082 [TBL] [Abstract][Full Text] [Related]
4. MG132 reverse the malignant characteristics of hypopharyngeal cancer. Ma J; Yu L; Tian J; Mu Y; Lv Z; Zou J; Li J; Wang H; Xu W Mol Med Rep; 2014 Jun; 9(6):2587-91. PubMed ID: 24691740 [TBL] [Abstract][Full Text] [Related]
5. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs]. Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142 [TBL] [Abstract][Full Text] [Related]
6. [Impact of cyclin-dependent kinase inhibitor p27 on resistance of ovarian cancer multicellular spheroids to taxol]. Xing H; Li J; Gao QL; Wu JH; Gao C; Lu YP; Ma D Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):37-41. PubMed ID: 12757643 [TBL] [Abstract][Full Text] [Related]
7. Construction of three-dimensional in vitro culture model of ovarian carcinoma and the study of its multicellular drug resistance. Lu M; Gao R; Xiao L; Wang Z J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):741-3. PubMed ID: 17357506 [TBL] [Abstract][Full Text] [Related]
8. Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance. Leisching G; Loos B; Botha M; Engelbrecht AM J Transl Med; 2015 Oct; 13():328. PubMed ID: 26474854 [TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer. Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417 [TBL] [Abstract][Full Text] [Related]
10. Involvement of NF-κB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells. Oiso S; Ikeda R; Nakamura K; Takeda Y; Akiyama S; Kariyazono H Oncol Rep; 2012 Jul; 28(1):27-32. PubMed ID: 22562377 [TBL] [Abstract][Full Text] [Related]
11. Salinomycin inhibits Akt/NF-κB and induces apoptosis in cisplatin resistant ovarian cancer cells. Parajuli B; Lee HG; Kwon SH; Cha SD; Shin SJ; Lee GH; Bae I; Cho CH Cancer Epidemiol; 2013 Aug; 37(4):512-7. PubMed ID: 23545383 [TBL] [Abstract][Full Text] [Related]
12. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells. Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365 [TBL] [Abstract][Full Text] [Related]
13. Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells. Rouette A; Parent S; Girouard J; Leblanc V; Asselin E Int J Cancer; 2012 Apr; 130(8):1755-67. PubMed ID: 21618512 [TBL] [Abstract][Full Text] [Related]
14. Proteasome Inhibitor MG132 Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells and Inhibits Tumor Growth. Sun F; Zhang Y; Xu L; Li S; Chen X; Zhang L; Wu Y; Li J Oncol Res; 2018 May; 26(4):655-664. PubMed ID: 29191257 [TBL] [Abstract][Full Text] [Related]
15. Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer. Wang Z; Li F; He S; Zhao L; Wang F Gene; 2022 Jan; 809():146003. PubMed ID: 34648915 [TBL] [Abstract][Full Text] [Related]
16. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells. Shehata M; Shehata M; Shehata F; Pater A Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959 [TBL] [Abstract][Full Text] [Related]
17. Reversion of multidrug resistance by SKI-II in SGC7901/DDP cells and exploration of underlying mechanisms. Zhu ZA; Zhu ZQ; Cai HX; Liu Y Asian Pac J Cancer Prev; 2012; 13(2):625-31. PubMed ID: 22524836 [TBL] [Abstract][Full Text] [Related]
18. [Experimental study on resistance to cisplatin and taxol in human ovarian cancer SKOV3ip1 multicellular aggregates]. Chen J; Feng Y; Zhou X Zhonghua Fu Chan Ke Za Zhi; 2001 Aug; 36(8):489-92. PubMed ID: 11758187 [TBL] [Abstract][Full Text] [Related]
19. Evidence of an association between human papillomavirus and impaired chemotherapy-induced apoptosis in cervical cancer cells. Padilla LA; Leung BS; Carson LF Gynecol Oncol; 2002 Apr; 85(1):59-66. PubMed ID: 11925121 [TBL] [Abstract][Full Text] [Related]
20. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells. Giuliano M; Lauricella M; Calvaruso G; Carabillò M; Emanuele S; Vento R; Tesoriere G Cancer Res; 1999 Nov; 59(21):5586-95. PubMed ID: 10554039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]